one director with IT knowledge or experience, while a Risk Supervision Committee must be established to provide assistance to the Board of Directors with regard to risk supervision. 3. Approval of the
investments; (such as Dusit Suites Ratchadamri, Bangkok and Dusit Hospitality Services Company Limited), the one-off items from the sales of the available for sales investment of THB 38 million in 2Q18 and the
investments; (such as Dusit Suites Ratchadamri, Bangkok and Dusit Hospitality Services Company Limited), the one-off items from the sales of the available for sales investment of THB 38 million in 2Q18 and the
million, declined from the wind power plant business being affected by seasonal factors, while the geothermal power plant recorded a decrease in profit from one-time financial expense for debt refinancing
increase of THB 2 million or 0.1%, comprised of the portion due within one year of THB 1,699 million and the rest of THB 1,089 million due in 2021. Shareholders' equity Total shareholders' equity as of
: Million Baht %YTD Accounts Receivable Total Assets Total Borrowing Total Liabilities Equity Attributable to Owners of the Parent 93,937 95,207 66,139 71,859 22,821 91,305 92,499 62,513 67,437 24,472 (3%) (3
-related businesses, the performance of BAC slightly decreased due to the loss of one airline customer at the beginning of the year. In part of BFS Ground, the revenue grew by 1.3 percent from growing number
performance of BAC slightly decreased due to the loss of one airline customer at the beginning of the year. In part of BFS Ground, the revenue grew by 1.3 percent from growing number of flights at Suvarnabhumi
947.96 (18.38) (1.94) Return on Equity (ROE) (%) 33.67% 26.37% 7.30% Return on Assets (ROA) (%) 20.72% 17.67% 3.05% Remark: * Calculated based on the number of issued and paid-up ordinary shares deducted
Company reported net loss attributable to the equity holder of the Company was 338.6 million baht. Loss per share for this quarter was 0.16 baht. Notable Event 1Q2020 Airline Business 1. The COVID-19